A total of @ eligible patients with locally advanced , unresectable or metastatic PDAC without previous system therapy were randomised to receive GEM at a dosage of @ mg/m ( @ ) d@ , @ , @ q@ versus a combination of SUNGEM at a dosage of GEM @ mg/m ( @ ) d@ +@ and sunitinib @mg p.o. d@-@ , q@d .